Nine new industry collaborations driving drug discovery forward
Drug Discovery World
MAY 29, 2024
ERS Genomics and IRBM ERS Genomics and IRBM have signed an agreement granting IRBM access to ERS’ CRISPR/Cas9 patent portfolio. Studies have found that EBV triggers a range of very serious health conditions including certain cancers and multiple sclerosis. We see a great need for a vaccine against EBV.”
52 
Let's personalize your content